These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19951667)

  • 1. [Proangiogenic cell-based therapy for treatment of ischemic diseases].
    Silvestre JS
    Med Sci (Paris); 2009 Nov; 25(11):931-8. PubMed ID: 19951667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
    Kawamoto A; Asahara T
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials.
    Ben-Shoshan J; George J
    Pharmacol Ther; 2007 Jul; 115(1):25-36. PubMed ID: 17574679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy.
    Foubert P; Matrone G; Souttou B; Leré-Déan C; Barateau V; Plouët J; Le Ricousse-Roussanne S; Lévy BI; Silvestre JS; Tobelem G
    Circ Res; 2008 Sep; 103(7):751-60. PubMed ID: 18723447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.
    Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ
    Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-enhancement strategies for the treatment of ischemic heart disease.
    Seeger FH; Zeiher AM; Dimmeler S
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S110-3. PubMed ID: 17230207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
    Marsboom G; Janssens S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell therapy of acute myocardial infarction: open questions.
    Dimmeler S; Zeiher AM
    Cardiology; 2009; 113(3):155-60. PubMed ID: 19122455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial progenitor cells as a therapeutic option in peripheral arterial disease.
    Devanesan AJ; Laughlan KA; Girn HR; Homer-Vanniasinkam S
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):475-81. PubMed ID: 19560945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative therapy for stroke.
    Chang YC; Shyu WC; Lin SZ; Li H
    Cell Transplant; 2007; 16(2):171-81. PubMed ID: 17474298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial progenitor cells--an evolving story.
    Pearson JD
    Microvasc Res; 2010 May; 79(3):162-8. PubMed ID: 20043930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients.
    Zhuo Y; Li SH; Chen MS; Wu J; Kinkaid HY; Fazel S; Weisel RD; Li RK
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1286-94, 1294.e1-2. PubMed ID: 19931095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of endothelial progenitor cells for regeneration of the vasculature.
    Yamahara K; Itoh H
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):17-27. PubMed ID: 19144668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based therapy of myocardial infarction.
    Dimmeler S; Burchfield J; Zeiher AM
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):208-16. PubMed ID: 17951319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments.
    Templin C; Lüscher TF; Landmesser U
    Int J Dev Biol; 2011; 55(4-5):407-17. PubMed ID: 21553380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization.
    Coppolino G; Buemi A; Bolignano D; Lacquaniti A; La Spada M; Stilo F; De Caridi G; Benedetto F; Loddo S; Buemi M; Spinelli F
    J Surg Res; 2009 Nov; 157(1):e129-35. PubMed ID: 19589539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy.
    Herrler T; Leicht SF; Huber S; Hermann PC; Schwarz TM; Kopp R; Heeschen C
    J Vasc Res; 2009; 46(4):333-46. PubMed ID: 19142013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue.
    Duan H; Cheng L; Sun X; Wu Y; Hu L; Wang J; Zhao H; Lu G
    Thromb Haemost; 2006 Dec; 96(6):807-15. PubMed ID: 17139377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoangiogenesis with endothelial precursors for the treatment of ischemia.
    Sepúlveda P; Martinez-León J; García-Verdugo JM
    Transplant Proc; 2007 Sep; 39(7):2089-94. PubMed ID: 17889103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases.
    Alev C; Ii M; Asahara T
    Antioxid Redox Signal; 2011 Aug; 15(4):949-65. PubMed ID: 21254837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.